share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144：拟议出售证券
美股SEC公告 ·  05/15 12:25
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Amit Sachdev is set to sell 32 shares of common stock on 05/15/2024, as per the latest filing. The shares, valued at an aggregate market value of $13,789.76, were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024, a day prior to the planned sale. The acquisition was made directly from the issuer and paid for in cash. This transaction follows a three-month period where a total of 10,449 shares were sold by the officer, generating gross proceeds of $4,414,711.53.
Vertex Pharmaceuticals Inc. officer Amit Sachdev is set to sell 32 shares of common stock on 05/15/2024, as per the latest filing. The shares, valued at an aggregate market value of $13,789.76, were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024, a day prior to the planned sale. The acquisition was made directly from the issuer and paid for in cash. This transaction follows a three-month period where a total of 10,449 shares were sold by the officer, generating gross proceeds of $4,414,711.53.
最新文件显示，Vertex Pharmicals Inc.高管阿米特·萨赫杰夫定于2024年5月15日出售32股普通股。这些股票的总市值为13,789.76美元，于2024年5月14日，即计划出售的前一天，通过员工股票购买计划（ESPP）收购。此次收购是直接从发行人处进行的，并以现金支付。此次交易是在三个月之后进行的，该高管共出售了10,449股股票，总收益为4,414,711.53美元。
最新文件显示，Vertex Pharmicals Inc.高管阿米特·萨赫杰夫定于2024年5月15日出售32股普通股。这些股票的总市值为13,789.76美元，于2024年5月14日，即计划出售的前一天，通过员工股票购买计划（ESPP）收购。此次收购是直接从发行人处进行的，并以现金支付。此次交易是在三个月之后进行的，该高管共出售了10,449股股票，总收益为4,414,711.53美元。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息